Aplastic Anemia in children, adolescents and adult patients
ERN-EuroBloodNet endorsed via EuroBloodNet Association three preceptorships held in ERN-EuroBloodNet' highly specialized centers for Aplastic Anemia (AA) to provide applicants with the fundamental tools for a correct diagnostic and treatment approach to Aplastic Anemia, adolescents, and adult patients.
Each preceptorship was accredited with Continuous Medical Education points issued from the European Board of Accreditation in Hematology and aimed to:
-
Train medical residents in haematology and young haematologists in patient care, including diagnostic tools, optimal use of available and new drugs, and in the field of Aplastic Anemia supportive care
-
Learn or improve medical resident in haematology and young haematologists knowledge in clinical research, including participation to registries and clinical trials
-
Stimulate cross-border collaborations between medical residents in haematology and young haematologists
Preceptorship on AA and PNH, developed within the ERN-EuroBloodNet framework, was sponsored by EuroBloodNet Association throught a grant supported by Pfizer.
Participants had to be affiliated to European Member States Healthcare providers.
Detailed information about each preceptorship program, including the agenda, is available by clicking the boxes below.
